06/01/2026
🚀 A New Neuromodulation Era Begins at Mindcare, Mandia 🚀
With the induction of the Soterix 1×1 Mini-CT, Mindcare Neuro Psychiatry Research Centre, Mandia enters an elite global group of institutions equipped with one of the world’s most scientifically validated and widely published transcranial electrical stimulation platforms.
Built on the Soterix 1×1 legacy—among the most cited and methodologically trusted systems in neuromodulation research—this device represents rigor, reproducibility, and clinical-trial–grade precision.
🌏 We dedicate this technology to the people of the North-East, with focused clinical and research commitment to:
1️⃣ Geriatric Psychiatry
Dementia & Cognitive Decline
Targeting memory, executive dysfunction, and functional deterioration with protocol-driven neuromodulation.
2️⃣ Child & Adolescent Psychiatry
Using advanced tRNS modes for Autism, ADHD, and emotional dysregulation, aligned with emerging neurodevelopmental research.
3️⃣ Other Routine Indications
Including mood disorders, anxiety spectra, neurocognitive rehabilitation, and adjunctive psychiatric care.
This is not about owning a device.
This is about bringing world-class brain science to regions that have historically been underserved—and doing it with ethics, evidence, and ambition.
The future of precision psychiatry in the North-East has begun.